Test Price
2,800 AED✅ Home Collection Available
PRNP Gene Gerstmann-Sträussler Disease Genetic Test in UAE – 2,800 AED
Executive Summary & Core Metrics
UAE’s Most Trusted PRNP Genetic Test – Key Performance Indicators
- ✓ Diagnostic Sensitivity: 99.9% via ISO 9001:2015 Accredited Next‑Generation Sequencing (Cert: INT/EGQ/2509DA/3139).
- ✓ Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection, available daily 8 AM to 11 PM.
- ✓ Post‑Test Support: Telephonic genetic counselling, clinical interpretation, and DHA‑licensed consultant medical genetics review.
- ✓ Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The PRNP Gene Gerstmann‑Sträussler Disease Genetic Test analyses the entire coding region of the prion protein gene using high‑depth Next‑Generation Sequencing to detect pathogenic mutations responsible for this rare autosomal dominant neurodegenerative prion disorder, delivering unparalleled diagnostic accuracy.
| Feature | DNA Labs UAE – NGS | Closest Alternative – Sanger |
|---|---|---|
| Methodology | Next‑Generation Sequencing (High‑Depth, ≥1000×) | Capillary Sanger Sequencing |
| Coverage | 99.9% coding region, splice sites & flanking intronic regions | Limited to single‑amplicon regions |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks (with reflex testing) |
| Diagnostic Sensitivity | ≥99.9% | ~95% (may miss large rearrangements) |
Physician Insight & Safety Protocols
A Note from Lina Osama Zaki Quteineh – Consultant Medical Genetics (DHA Registration ID: 9294403):
“As a consultant medical genetics specialist, I emphasise that a pathogenic PRNP variant confirms susceptibility to Gerstmann‑Sträussler‑Scheinker disease but does not predict age of onset or disease severity. This result must always be interpreted within the full clinical context, including family pedigree, neurological examination, and neuroimaging. Mandatory pre‑ and post‑test genetic counselling is essential to contextualise risk and guide family screening. Please never discontinue or alter prescribed therapy without consulting your supervising physician.”
Clinical Advisory & Medication Guidance
Do not stop, start, or modify any prescribed medication based solely on genetic test results. Always consult your supervising physician for therapeutic adjustments. This test provides risk information and is not a standalone diagnostic tool for acute clinical decision‑making.
Advisory: Do not discontinue prescribed therapy without consulting your doctor.
Patient Exclusion Criteria & Safety Precautions
- Exclusion Criteria: Active bleeding disorder or severe anaemia precluding safe venipuncture; minors under 18 years of age without documented legal guardian consent as per Federal Decree‑Law No. 4 of 2016 on Medical Liability; individuals unable to provide informed consent; samples that fail pre‑analytical quality thresholds.
- Emergency Red Flags: Rapidly progressive dementia, myoclonus, severe ataxia, or any acute focal neurological deficit – seek immediate medical attention. Do not rely solely on genetic test results for urgent clinical decisions.
Patient FAQ & Clinical Guidance
1. What is the purpose of the PRNP gene genetic test?
The PRNP gene Next‑Generation Sequencing test detects pathogenic mutations that cause Gerstmann‑Sträussler‑Scheinker disease and other familial prion disorders, enabling early diagnosis, family risk stratification, and cascade screening with 99.9% diagnostic sensitivity.
2. How is the sample collected and transported?
A certified phlebotomist performs a standard venipuncture to collect peripheral whole blood. The specimen is transported via VIP Mobile Phlebotomy with temperature‑controlled cold‑chain logistics, ensuring pre‑analytical integrity from collection to laboratory processing.
3. When will I receive my results and what support is provided?
Results are issued within 3–4 weeks from sample receipt. Each report includes comprehensive genetic counselling and a detailed medical interpretation by a DHA‑licensed Consultant Medical Genetics specialist, with a follow‑up telephonic consultation to discuss clinical implications.
UAE Regulatory & Data Privacy Adherence
Your Data. Your Trust. Our Commitment.
- Data Protection: All genetic and personal data are processed in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health Data Governance: Electronic health records and genetic test data are handled under Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Accreditation: ISO 9001:2015 Certified – Cert. No. INT/EGQ/2509DA/3139. DHA Facility License No. 1143.
- Clinical Safety: Patient consent and medical liability protections are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | PRNP Gene Gerstmann‑Sträussler Disease Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection Available |
| Methodology Used | Next‑Generation Sequencing (NGS) – High‑Depth, Full Coding Region & Splice Sites |
| ICD-10-CM Code | A81.82 |
| LOINC Code | 21656-1 |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians